Literature DB >> 22921835

D6: the 'crowd controller' at the immune gateway.

Kit Ming Lee1, Robert J B Nibbs, Gerard J Graham.   

Abstract

The chemokine-scavenging receptor, D6, is reported to regulate resolution of inflammatory responses. However, recent data also point to an unanticipated role for D6 in coordinating innate and adaptive immune responses. Here, we propose that D6 is essential for preventing inflammatory leukocyte association with lymphatic vasculature. In the absence of D6, inappropriate inflammatory leukocyte accumulation around lymphatic endothelium congests the lymphatic system, impairing fluid and cellular flow from inflamed sites to lymph nodes and reducing efficiency of antigen presentation. Thus, the inability of D6-deficient mice to resolve inflammation may be a byproduct of impaired fluid drainage from inflamed sites and thus we provide a model unifying D6 function in innate and adaptive immune responses.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22921835     DOI: 10.1016/j.it.2012.08.001

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  17 in total

1.  Local apoptosis mediates clearance of macrophages from resolving inflammation in mice.

Authors:  Emmanuel L Gautier; Stoyan Ivanov; Philippe Lesnik; Gwendalyn J Randolph
Journal:  Blood       Date:  2013-08-23       Impact factor: 22.113

2.  Steady-state antigen scavenging, cross-presentation, and CD8+ T cell priming: a new role for lymphatic endothelial cells.

Authors:  Sachiko Hirosue; Efthymia Vokali; Vidya R Raghavan; Marcela Rincon-Restrepo; Amanda W Lund; Patricia Corthésy-Henrioud; Francesca Capotosti; Cornelia Halin Winter; Stéphanie Hugues; Melody A Swartz
Journal:  J Immunol       Date:  2014-05-02       Impact factor: 5.422

3.  Cell-autonomous regulation of neutrophil migration by the D6 chemokine decoy receptor.

Authors:  Antal Rot; Clive McKimmie; Claire L Burt; Kenneth J Pallas; Thomas Jamieson; Monika Pruenster; Richard Horuk; Robert J B Nibbs; Gerard J Graham
Journal:  J Immunol       Date:  2013-05-13       Impact factor: 5.422

Review 4.  Immune regulation by atypical chemokine receptors.

Authors:  Robert J B Nibbs; Gerard J Graham
Journal:  Nat Rev Immunol       Date:  2013-11       Impact factor: 53.106

5.  The chemokine receptors ACKR2 and CCR2 reciprocally regulate lymphatic vessel density.

Authors:  Kit M Lee; Renzo Danuser; Jens V Stein; Delyth Graham; Robert J B Nibbs; Gerard J Graham
Journal:  EMBO J       Date:  2014-09-30       Impact factor: 11.598

Review 6.  Atypical Chemokine Receptors and Their Roles in the Resolution of the Inflammatory Response.

Authors:  Raffaella Bonecchi; Gerard J Graham
Journal:  Front Immunol       Date:  2016-06-10       Impact factor: 7.561

Review 7.  Targeting the CCL2-CCR2 signaling axis in cancer metastasis.

Authors:  Su Yin Lim; Arseniy E Yuzhalin; Alex N Gordon-Weeks; Ruth J Muschel
Journal:  Oncotarget       Date:  2016-05-10

8.  Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation.

Authors:  Michal Abraham; Hanna Wald; Dalit Vaizel-Ohayon; Valentin Grabovsky; Zohar Oren; Arnon Karni; Lola Weiss; Eithan Galun; Amnon Peled; Orly Eizenberg
Journal:  Front Immunol       Date:  2017-11-23       Impact factor: 7.561

9.  Microarray analyses demonstrate the involvement of type I interferons in psoriasiform pathology development in D6-deficient mice.

Authors:  Helen M Baldwin; Kenneth Pallas; Vicky King; Thomas Jamieson; Clive S McKimmie; Robert J B Nibbs; José M Carballido; Marcus Jaritz; Antal Rot; Gerard J Graham
Journal:  J Biol Chem       Date:  2013-11-05       Impact factor: 5.157

10.  The N-terminal region of the atypical chemokine receptor ACKR2 is a key determinant of ligand binding.

Authors:  Kay D Hewit; Alasdair Fraser; Robert J B Nibbs; Gerard J Graham
Journal:  J Biol Chem       Date:  2014-03-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.